19.03.2024 • News

2024 Guidance Suspended: API Production Paused in Brindisi, Italy

EuroAPI today announces that its Italian subsidiary, EuroAPI Italy S.R.L., is suspending the production of all APIs (active pharmaceutical ingredients) in Brindisi.

An internal audit at EuroAPI has uncovered potential misconduct leading to quality control issues. Production is on hold pending further investigation. Health authorities have been notified and a forensic audit is underway. Customers will be updated as more information becomes available.

The Brindisi site, which primarily produces anti-infective APIs, generated sales of 63 million euros in 2023, with 43% related to Sanofi. However, due to full impairment of its non-current assets in the 2023 accounts, the Group’s performance is expected to be impacted. As a result, the 2024 guidance is suspended, with a revised outlook to be provided in Q2 2024. This will coincide with updates on the FOCUS-27 project announced on February 28th, 2024.

Company

Logo:

EuroAPI

15 rue Traversière
75012 Paris
France

Company contact







Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature

most read